Diversify Out of Crypto: SINK YOUR TEETH INTO THIS!
The biggest winners in the markets have been in the legalized cannabis industry. The revenues have been outstanding, and because we positioned early, we’ve made absolutely remarkable returns in a short period of time.
This niche in the vast global economy is more potent and profitable right now than it has ever been. Bill C-45 (a.k.a. the Cannabis Act) has already made marijuana sales and use 100% legal for adults across Canada, and in the U.S., there are now 33 states with pro-medical marijuana laws, plus 10 states and Washington, D.C. with pro-recreational cannabis laws in effect.
The traditional news outlets are mainly reporting on the licensed producers in North America, and there’s certainly plenty of money to be made in this area, but Pure Blockchain Wealth has uncovered a unique window of opportunity that’s going to be truly lucrative in 2019 and beyond – a huge gap in the market that desperately needs to be filled.
The real game-changers in the legal cannabis industry are the companies that invest in the development of plant improvements through modern genome tools and technology. . Genetics is where next year’s cannabis superstars will be made, as recreational users of the now-legal product crave new variations while medical patients demand solutions to a host of ailments:
Courtesy: Leaf Science
I’ve been making moves personally, quietly, in my own portfolio as well, by getting into the cannabis genetics market before the big gains are made and stock prices become expensive.
In particular, I’m building a position in a one specific company with diversified cannabis holdings, a wide distribution network, and a plant genetics program that is absolutely nonpareil: TILT Holdings Inc. (CSE: TILT).
This is a broadly-diversified company with a powerful presence in software, distribution analytics, construction, capital support, and intellectual property management, but it’s the genetics program that impressed me the most.
TILT’s three-phase, cutting-edge Cannabis Molecular Breeding Program is truly unrivaled in the industry. From discovery to purification and hybrid seed production, TILT’s genetics team is applying genome tools and technologies to accelerate plant improvement and develop new seeds to solve the inherent challenges of cloned plants:
Courtesy: TILT Holdings Inc.
TILT’s Cannabis Molecular Breeding Program will have deep commercial impact on multiple facets of the plant genetics field: better predictive breeding, more uniform plant architecture, consistent productivity, and maximized genetic potential will be just a few of the improvements that TILT will contribute to the science of breeding legal cannabis.
With a business platform providing the infrastructure, technology, people, and capital to accelerate growth across the North American legal marijuana industry, TILT’s vertical cannabis solution is unmatched and unbeatable. And with their unique and best-in-class Cannabis Molecular Breeding Program, there’s no limit to the revenues TILT can generate in the coming months and years.
2019 will be the breakout year for cannabis and I’m looking at plant genetics as the next frontier to be conquered. For TILT Holdings Inc., it’s an opportunity to provide tremendous shareholder value – an investment now is your ticket to wealth in the very near future.
Governments Have Amassed ungodly Debt Piles and Have Promised Retirees Unreasonable Amounts of Entitlements, Not In Line with Income Tax Collections. The House of Cards Is Set To Be Worse than 2008! Rising Interest Rates Can Topple The Fiat Monetary Structure, Leaving Investors with Less Than Half of Their Equity Intact!
Protect Yourself Now, By Building A Fully-Hedged Financial Fortress!